Instil Bio, Inc. Other Non-Current Assets
Instil Bio, Inc. (TIL) had Other Non-Current Assets of $3.91 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Noncurrent $3.91M.
- 2026-03-31: Other Assets, Noncurrent $3.99M.
- 2025-12-31: Other Assets, Noncurrent $4.07M.
- 2025-09-30: Other Assets, Noncurrent $4.15M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $3.91M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.99M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $4.07M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.15M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $11.20M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $10.07M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $4.49M 10-K · filed 2026-03-27 | $8.76M 10-K · filed 2025-03-04 |
| 2024-09-30 | $6.18M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $581.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.77M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $639.00K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $2.54M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.10M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.63M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.41M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $5.01M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.25M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $3.08M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $8.14M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $4.79M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.81M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.70M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.71M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |